Taylor Guo is the founder of I-Mab Biopharma. I-Mab Biopharma has raised $500M in total funding. Latest round: Post-IPO Equity. Based in Shanghai, China.
Taylor Guo serves as the Chief Scientific Officer at I-Mab Biopharma, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel biologics. I-Mab is expanding its oncology therapeutic pipeline through collaborations with biotech companies utilizing cutting-edge mRNA and AI technology platforms.
Full founder directory · Investor directory · Company funding database · Fundraising library